ProDex Inc (PDEX)

Healthcare | Medical Instruments Supplies
Income Statement (Quarterly) 2025-09-30 2025-03-31 2024-12-31 2024-09-30
Revenue 18,530,000 17,414,000 16,793,000 14,892,000
Cost of Revenue 13,163,000 11,616,000 11,721,000 9,742,000
Gross Profit 5,367,000 5,798,000 5,072,000 5,150,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,490,000 1,211,000 1,438,000 1,294,000
Operating Expenses 2,258,000 2,158,000 2,380,000 2,137,000
Operating Income 3,109,000 3,640,000 2,692,000 3,013,000
Interest Expense -200,000 0 204,000 152,000
Income Before Tax 6,222,000 4,554,000 2,586,000 3,319,000
Income Tax Expense 1,542,000 1,279,000 546,000 853,000
Net Income 4,680,000 3,275,000 2,040,000 2,466,000
Per Share
EPS 1.43 1.00 0.63 0.76
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 66,593,000 53,844,000 46,087,000 42,041,000 38,029,000
Cost of Revenue 47,083,000 39,293,000 33,338,000 28,909,000 24,454,000
Gross Profit 19,510,000 14,551,000 12,749,000 13,132,000 13,575,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 5,185,000 4,189,000 4,183,000 4,994,000 4,666,000
Operating Expenses 8,821,000 7,378,000 6,987,000 7,974,000 9,050,000
Operating Income 10,689,000 7,173,000 5,762,000 5,123,000 4,525,000
Interest Expense 829,000 558,000 533,000 464,000 352,000
Income Before Tax 12,058,000 2,634,000 9,428,000 4,706,000 5,626,000
Income Tax Expense 3,080,000 507,000 2,354,000 851,000 1,176,000
Net Income 8,978,000 2,127,000 7,074,000 4,572,000 4,450,000
Per Share
EPS 2.73 0.61 1.98 1.26 1.17
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 419,000 2,631,000 2,936,000 849,000
Short Term Investments 6,740,000 4,217,000 1,134,000 755,000
Net Receivables 17,489,000 13,887,000 9,952,000 15,384,000
Inventory 22,213,000 15,269,000 16,167,000 12,678,000
Total Current Assets 47,295,000 36,611,000 30,979,000 31,166,000
Property Plant Equipment 1,050,000 12,652,000 13,200,000 13,424,000
Goodwill and Intangibles 26,000 54,000 81,000 118,000
Total Assets 61,192,000 52,477,000 51,823,000 47,326,000
Liabilities
Account Payables 4,614,000 4,513,000 2,261,000 3,761,000
Short Term Debt 6,646,000 4,829,000 4,243,000 3,285,000
Total Current Liabilities 14,629,000 12,892,000 9,676,000 10,810,000
Long Term Debt 9,931,000 8,718,000 10,549,000 12,304,000
Total Liabilities 24,560,000 21,610,000 20,233,000 23,658,000
Shareholders Equity
Retained Earnings 35,928,000 26,950,000 24,823,000 15,986,000
Total Shareholders Equity 36,632,000 30,867,000 31,590,000 23,668,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 419,000 2,631,000 2,936,000 849,000 3,721,000
Short Term Investments 6,740,000 4,217,000 1,134,000 755,000 1,295,000
Net Receivables 17,489,000 13,887,000 9,952,000 15,384,000 10,933,000
Inventory 22,213,000 15,269,000 16,167,000 12,678,000 8,437,000
Total Current Assets 47,295,000 36,611,000 30,979,000 31,166,000 25,013,000
Property Plant Equipment 1,050,000 12,652,000 13,200,000 13,424,000 12,887,000
Goodwill and Intangibles 26,000 54,000 81,000 118,000 186,000
Total Assets 61,192,000 52,477,000 51,823,000 47,326,000 40,320,000
Liabilities
Account Payables 4,614,000 4,513,000 2,261,000 3,761,000 2,288,000
Short Term Debt 6,646,000 4,829,000 4,243,000 3,285,000 1,580,000
Total Current Liabilities 14,629,000 12,892,000 9,676,000 10,810,000 5,872,000
Long Term Debt 9,931,000 8,718,000 10,549,000 12,304,000 13,967,000
Total Liabilities 24,560,000 21,610,000 20,233,000 23,658,000 20,236,000
Shareholders Equity
Retained Earnings 35,928,000 26,950,000 24,823,000 15,986,000 12,346,000
Total Shareholders Equity 36,632,000 30,867,000 31,590,000 23,668,000 20,084,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income 8,978,000 2,127,000 7,074,000 3,855,000
Depreciation & Amortization 1,239,000 1,160,000 857,000 726,000
Stock Based Compensation 555,000 605,000 766,000 1,275,000
Change in Working Capital -10,454,000 -225,000 396,000 -6,537,000
Operating Cash Flow -1,682,000 6,199,000 5,462,000 -847,000
Investing Activities
Capital Expenditure -1,246,000 -983,000 -974,000 -1,671,000
Investments -1,246,000 -983,000 -974,000 -1,671,000
Investing Cash Flow -238,000 -2,233,000 -885,000 -1,235,000
Financing Activities
Debt Repayment 3,475,000 -816,000 -809,000 -1,244,000
Common Stock Issued/Repurchased -3,462,000 -3,505,000 -1,458,000 -1,546,000
Dividends Paid 0 0 0 0
Financing Cash Flow -292,000 -4,271,000 -2,490,000 -790,000
Summary
Free Cash Flow -2,928,000 5,216,000 4,488,000 -2,518,000
Net Change in Cash -2,212,000 -305,000 2,087,000 -2,872,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income 8,978,000 2,127,000 7,074,000 3,855,000 4,450,000
Depreciation & Amortization 1,239,000 1,160,000 857,000 726,000 686,000
Stock Based Compensation 555,000 605,000 766,000 1,275,000 901,000
Change in Working Capital -10,454,000 -225,000 396,000 -6,537,000 -6,687,000
Operating Cash Flow -1,682,000 6,199,000 5,462,000 -847,000 -2,078,000
Investing Activities
Capital Expenditure -1,246,000 -983,000 -974,000 -1,671,000 -8,306,000
Investments -1,246,000 -983,000 -974,000 -1,671,000 -8,268,000
Investing Cash Flow -238,000 -2,233,000 -885,000 -1,235,000 -3,710,000
Financing Activities
Debt Repayment 3,475,000 -816,000 -809,000 -1,244,000 -351,000
Common Stock Issued/Repurchased -3,462,000 -3,505,000 -1,458,000 -1,546,000 -5,537,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow -292,000 -4,271,000 -2,490,000 -790,000 3,088,000
Summary
Free Cash Flow -2,928,000 5,216,000 4,488,000 -2,518,000 -10,384,000
Net Change in Cash -2,212,000 -305,000 2,087,000 -2,872,000 -2,700,000